Network origin in Hyuk Joon Ko first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Hyuk Joon Ko via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Investor Relations Contact | |
| University of London | College/University | Doctorate Degree | |
| The King's College (New York) | College/University | Undergraduate Degree | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Kent County Memorial Hospital
 Kent County Memorial Hospital Hospital/Nursing ManagementHealth Services Kent County Memorial Hospital provides health care services. It also provides inpatient services including cardiology and extended coronary care, infectious disease, primary care, oncology, orthopedics, obstetrics and gynecology, pediatrics, rehabilitation and surgery. The company was founded in 1951 and is headquartered in Warwick, RI. | Hospital/Nursing Management | Corporate Officer/Principal | |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| EFFECTOR THERAPEUTICS, INC. | Biotechnology | Consultant / Advisor | |
St. Thomas Hospital, Inc.
 St. Thomas Hospital, Inc. Hospital/Nursing ManagementHealth Services St. Thomas Hospital, Inc. operates hospitals. The private company is based in St. Thomas, VI. and has subsidiaries in United States. | Hospital/Nursing Management | Corporate Officer/Principal | |
Claris Ventures Sgr SpA
 Claris Ventures Sgr SpA Investment ManagersFinance Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy. | Investment Managers | Private Equity Investor | |
Resalis Therapeutics SRL
 Resalis Therapeutics SRL Miscellaneous Commercial ServicesCommercial Services Resalis Therapeutics SRL is a company that focuses on developing a transformative metabolic disease approach to target obesity and fatty liver disease. The company is based in Turin, Italy. The Italian company's lead program, RES-010, is a safe and convenient treatment that provides disease-modifying therapeutic impact, including durable weight loss and reduction of hepatic steatosis. The CEO of the company is Eva Castagnetti. | Miscellaneous Commercial Services | Director/Board Member | |
| Alta Capital Group | Chief Executive Officer | ||
| Harvard College | College/University | Undergraduate Degree | |
| Stanford Graduate School of Business | College/University | Masters Business Admin | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Pharmaceuticals: Major | Consultant / Advisor | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Public Communications Contact | |
| JOKWANG ILI CO., LTD. | Industrial Machinery | Comptroller/Controller/Auditor | |
| University of Massachusetts | College/University | Undergraduate Degree | |
| ALKERMES PLC | Pharmaceuticals: Major | Public Communications Contact | |
National Investor Relations Institute
 National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Tufts University School of Medicine | College/University | Graduate Degree | |
| Emerson College | College/University | Graduate Degree | |
| DICERNA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Public Communications Contact | |
Shinhan Venture Investment Co. Ltd.
 Shinhan Venture Investment Co. Ltd. Investment ManagersFinance Shinhan Venture Investment Co. Ltd. (Shinhan Venture Investment) is a Private Equity/Venture Capital firm, a subsidiary of Shinhan Venture Investment founded in 2000. The firm headquartered in Seoul. | Investment Managers | Private Equity Investor | |
| Pohang University | College/University | Undergraduate Degree | |
| US Air Force | Sovereign | Consultant / Advisor | |
| CBI CO., LTD. | Auto Parts: OEM | Director/Board Member | |
| HUM&C CO., LTD. | Household/Personal Care | Director/Board Member | |
| Graduate School of Environmental Studies Seoul Natl University | College/University | Undergraduate Degree | |
Adjuvant Capital LP
 Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | Investment Managers | Consultant / Advisor | |
| Wright State University (Ohio) | College/University | Graduate Degree | |
| Brody School of Medicine | College/University | Doctorate Degree | |
| East Carolina University | College/University | Graduate Degree | |
ENGIE North America, Inc.
 ENGIE North America, Inc. Electric UtilitiesUtilities ENGIE North America, Inc. engages in electricity generation and cogeneration activities through wind, hydro, solar, biomass and biogas, coal, and natural gas facilities. It offers natural gas pipeline systems to government power generation sites. The company was founded in 1989 and is headquartered in Houston, TX. | Electric Utilities | Comptroller/Controller/Auditor |
Statistics
International
| United States | 25 |
| South Korea | 7 |
| United Kingdom | 3 |
| Italy | 3 |
| Denmark | 2 |
Sectoral
| Consumer Services | 13 |
| Health Technology | 12 |
| Finance | 4 |
| Health Services | 3 |
| Commercial Services | 3 |
Operational
| Director/Board Member | 10 |
| Undergraduate Degree | 7 |
| Corporate Officer/Principal | 5 |
| Public Communications Contact | 5 |
| Consultant / Advisor | 5 |
Most connected contacts
| Insiders | |
|---|---|
| Michael Hodges | 21 |
| Rebecca J. Peterson | 9 |
| Ji-Young Hwang | 7 |
| Paul Kang | 4 |
| Joshua Miller | 2 |
| Dongho Lee | 1 |
| Hojoon Lee | 1 |
| Minhee Eom | 1 |
- Stock Market
- Insiders
- Hyuk Joon Ko
- Company connections
